UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Quarterly Period Ended December 28, 2003
or
| ¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File No. 0-8866
MICROSEMI CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 95-2110371 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
| 2381 Morse Avenue, Irvine, California | 92614 | |
| (Address of principal executive offices) | (Zip Code) | |
(949) 221-7100
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨
The number of shares of the issuers Common Stock, $0.20 par value, outstanding on February 3, 2004 was 29,566,203 (59,432,406 as adjusted to reflect a 2-for-1 stock split to be effected by a stock dividend, the record date is February 6, 2004 and the ex-dividend date is February 23, 2004).
PART I - FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
The unaudited consolidated income statements for the three months ended December 28, 2003 of Microsemi Corporation and Subsidiaries (Microsemi, the Company, we, our, ours and us), the unaudited consolidated statements of cash flows for the three months ended December 28, 2003, and the comparative unaudited consolidated financial information for the corresponding period of the prior year, together with our balance sheets as of December 28, 2003 (unaudited) and as of September 28, 2003, are attached hereto and incorporated herein.
2
MICROSEMI CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(amounts in thousands, except share data)
| September 28, 2003 |
December 28, 2003 |
|||||||
| (Unaudited) | ||||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 29,353 | $ | 35,617 | ||||
| Accounts receivable, net of allowance for doubtful accounts, $1,445 at September 28, 2003 and $1,454 at December 28, 2003 |
28,866 | 28,874 | ||||||
| Inventories |
53,679 | 53,759 | ||||||
| Deferred income taxes |
5,239 | 5,239 | ||||||
| Other current assets |
1,234 | 1,507 | ||||||
| Total current assets |
118,371 | 124,996 | ||||||
| Property and equipment, net |
62,973 | 61,992 | ||||||
| Deferred income taxes |
10,162 | 10,162 | ||||||
| Goodwill |
3,258 | 3,258 | ||||||
| Other intangible assets, net |
6,622 | 6,319 | ||||||
| Other assets |
4,257 | 4,316 | ||||||
| TOTAL ASSETS |
$ | 205,643 | $ | 211,043 | ||||
| LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
| Current liabilities: |
||||||||
| Notes payable |
$ | 121 | $ | 121 | ||||
| Current maturity of long-term debt |
89 | 89 | ||||||
| Accounts payable |
11,918 | 11,579 | ||||||
| Accrued liabilities |
14,910 | 15,348 | ||||||
| Income taxes payable |
4,165 | 5,299 | ||||||
| Total current liabilities |
31,203 | 32,436 | ||||||
| Long-term debt |
449 | 436 | ||||||
| Other long-term liabilities |
4,131 | 4,067 | ||||||
| Stockholders equity (see Note 10): |
||||||||
| Preferred stock, $1.00 par value; authorized 1,000 shares; none issued |
| | ||||||
| Common stock, $0.20 par value; authorized 100,000 shares; issued and outstanding 29,102 (58,204 after split) and 58,808 at September 28, 2003 and December 28, 2003, respectively |
5,821 | 11,763 | ||||||
| Capital in excess of par value of common stock |
120,134 | 116,091 | ||||||
| Retained earnings |
43,915 | 46,269 | ||||||
| Accumulated other comprehensive loss |
(10 | ) | (19 | ) | ||||
| Total stockholders equity |
169,860 | 174,104 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY |
$ | 205,643 | $ | 211,043 | ||||
The accompanying notes are an integral part of these statements
3
MICROSEMI CORPORATION AND SUBSIDIARIES
Unaudited Consolidated Income Statements
(amounts in thousands, except earnings per share)
| Quarters Ended | |||||||
| December 29, 2002 |
December 28, 2003 | ||||||
| Net sales |
$ | 45,869 | $ | 54,945 | |||
| Cost of sales |
32,840 | 36,763 | |||||
| Gross profit |
13,029 | 18,182 | |||||
| Operating expenses: |
|||||||
| Selling, general and administrative |
9,017 | 9,707 | |||||
| Research and development |
4,963 | 4,750 | |||||
| Amortization of other intangible assets |
323 | 302 | |||||
| Restructuring charges |
686 | | |||||
| Loss on sale of asset, net |
428 | | |||||
| Total operating expenses |
15,417 | 14,759 | |||||
| Operating income (loss) |
(2,388 | ) | 3,423 | ||||
| Other income (expense): |
|||||||
| Interest, net |
(30 | ) | 78 | ||||
| Other, net |
(30 | ) | 12 | ||||
| Total other expense |
(60 | ) | 90 | ||||
| Income (loss) before income taxes |
(2,448 | ) | 3,513 | ||||
| Provision (benefit) for income taxes |
(808 | ) | 1,159 | ||||
| Income (loss) before cumulative effect of a change in accounting principle |
$ | (1,640 | ) | $ | 2,354 | ||
| Cumulative effect of a change in accounting principle, net of income taxes |
(14,655 | ) | | ||||
| NET INCOME (LOSS) |
$ | (16,295 | ) | $ | 2,354 | ||
| Basic and Diluted earnings (loss) per share (see Note 10): |
|||||||
| Earnings before cumulative effect of a change in accounting principle |
$ | (0.03 | ) | $ | 0.04 | ||
| Cumulative effect of a change in accounting principle |
(0.25 | ) | | ||||
| Earnings (loss) per share |
$ | (0.28 | ) | $ | 0.04 | ||
| Common and common equivalent shares outstanding: |
|||||||
| Basic |
57,811 | 58,379 | |||||
| Diluted |
57,811 | 61,402 | |||||
The accompanying notes are an integral part of these statements.
4
MICROSEMI CORPORATION AND SUBSIDIARIES
Unaudited Consolidated Statements of Cash Flows
(amounts in thousands)
| Quarters Ended |
||||||||
| December 29, 2002 |
December 28, 2003 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income (loss) |
$ | (16,295 | ) | $ | 2,354 | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
2,718 | 2,943 | ||||||
| Provision for doubtful accounts |
131 | 24 | ||||||
| Loss on retirement and disposition of assets |
428 | 7 | ||||||
| Impairment of assets |
368 | | ||||||
| Impairment of goodwill, net of income taxes |
14,655 | | ||||||
| Changes in assets and liabilities: |
||||||||
| Accounts receivable |
2,649 | (32 | ) | |||||
| Inventories |
1,258 | (80 | ) | |||||
| Other current assets |
(574 | ) | (156 | ) | ||||
| Other assets |
(13 | ) | | |||||
| Accounts payable |
(2,382 | ) | (339 | ) | ||||
| Accrued liabilities |
52 | 511 | ||||||
| Income taxes payable |
| 1,134 | ||||||
| Other long-term liabilities |
14 | (64 | ) | |||||
| Net cash provided by operating activities |
3,009 | 6,302 | ||||||
| Cash flow from investing activities: |
||||||||
| Purchases of property and equipment |
(2,675 | ) | (1,857 | ) | ||||
| Changes in other assets |
1,268 | (58 | ) | |||||
| Proceeds from sales of assets |
2,425 | | ||||||
| Net cash provided by (used in) investing activities |
1,018 | (1,915 | ) | |||||
| Cash flows from financing activities: |
||||||||
| Payments of long-term debt |
(18 | ) | (13 | ) | ||||
| Exercise of employee stock options |
100 | 1,899 | ||||||
| Net cash provided by financing activities |
82 | 1,886 | ||||||
| Effect of exchange rate changes on cash |
(10 | ) | (9 | ) | ||||
| Net increase in cash and cash equivalents |
4,099 | 6,264 | ||||||
| Cash and cash equivalents at beginning of period |
23,060 | 29,353 | ||||||
| Cash and cash equivalents at end of period |
$ | 27,159 | $ | 35,617 | ||||
The accompanying notes are an integral part of these statements.
5
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
December 28, 2003
1. PRESENTATION OF FINANCIAL INFORMATION
The financial information furnished herein is unaudited, but in the opinion of management, includes all adjustments (all of which are normal, recurring adjustments) necessary for a fair presentation of the results of operations for the periods indicated. The results of operations for the first quarter of the current fiscal year are not necessarily indicative of the results to be expected for the full year.
The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q, and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. The unaudited consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto in the Annual Report on Form 10-K for the fiscal year ended September 28, 2003.
2. INVENTORIES
Inventories used in the computation of cost of goods sold were (amounts in thousands):
| September 28, 2003 |
December 28, 2003 | |||||
| Raw materials |
$ | 13,696 | $ | 13,623 | ||
| Work in process |
25,505 | 26,990 | ||||
| Finished goods |
14,478 | 13,146 | ||||
| $ | 53,679 | $ | 53,759 | |||
3. CONTINGENCY
In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by a subsidiary of ours had notified the subsidiary and other parties, claiming that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc., former owners of the manufacturing facility, agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although TCE and other contaminants previously used at the facility are present in soil and groundwater on the subsidiarys property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with three former owners of this facility whereby they 1) reimbursed us for $530,000 of past costs, 2) assume responsibility for 90% of all future clean-up costs, and 3) indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5,300,000; accordingly, we recorded a charge of $530,000 for this project in fiscal year 2003. There has not been any significant development since September 28, 2003.
We are involved in various pending litigation matters, arising out of the normal conduct of our business, including from time to time litigation relating to commercial transactions, contracts, and environmental matters. In the opinion of management, the final outcome of these matters will not have a material adverse effect on our financial position, results of operations or cash flows.
6
4. COMPREHENSIVE INCOME
Comprehensive income is defined as the change in equity (net assets) of a business enterprise during the period from transactions and other events and circumstances from non-owner sources. Comprehensive income consists of net income and the change of the cumulative translation adjustment. Accumulated other comprehensive loss consists of the cumulative foreign currency translation adjustment. Total comprehensive income (loss) for the quarters ended December 29, 2002 and December 28, 2003 were calculated as follows (amounts in 000s):
| Quarters Ended |
||||||||
| December 29, 2002 |
December 28, 2003 |
|||||||
| Net Income (loss) |
$ | (16,295 | ) | $ | 2,354 | |||
| Translation adjustment |
$ | (10 | ) | $ | (9 | ) | ||
| Comprehensive Income (loss) |
$ | (16,305 | ) | $ | 2,345 | |||
5. EARNINGS PER SHARE
Basic earnings per share have been computed based upon the weighted average number of common shares outstanding during the respective periods. Diluted earnings per share have been computed, when the result is dilutive, using the treasury stock method for stock options outstanding and giving effect to issuance of shares upon conversion of debt during the respective periods.
On January 26, 2004, we announced a 2-for-1 stock split of shares of our common stock to be effected by means of a stock dividend. This stock split has been reflected in the following calculation of earnings per share for all periods presented (see Note 10).
Earnings per share (EPS) for the respective quarters ended December 29, 2002 and December 28, 2003 were calculated as follows (amounts in thousands, except per share data):
| Quarters Ended | |||||||
| December 29, 2002 |
December 28, 2003 | ||||||
| BASIC |
|||||||
| Net income (loss) |
$ | (16,295 | ) | $ | 2,354 | ||
| Weighted-average common shares outstanding |
57,811 | 58,379 | |||||
| Basic earnings (loss) per share |
$ | (0.28 | ) | $ | 0.04 | ||
| DILUTED |
|||||||
| Net income (loss) |
$ | (16,295 | ) | $ | 2,354 | ||